John R Lozada

11PUBLICATIONS
79CO-AUTHORS
Innate immunityHaematological tumoursMolecular targetsMedical molecular engineering of nucleic acids and proteinsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Feb 27, 2026
Integrated Single-Cell Profiling Reveals Dichotomous NK Cell Populations Associated with Immunosuppression in Solid Tumors.

John R Lozada, Atef Ali, Christine Luo

|Aug 26, 2025
Chronic NK cell activation results in a dysfunctional, tissue resident-like state mediated by KLF2 deficiency.

Jacob A Myers, Rih-Sheng Huang, Shee Kwan Phung

|Jan 28, 2025
Expression Patterns of DLL3 across Neuroendocrine and Non-neuroendocrine Neoplasms Reveal Broad Opportunities for Therapeutic Targeting.

John R Lozada, Andrew Elliott, Mark G Evans

|May 06, 2024
Pan-Cancer Interrogation of B7-H3 (CD276) as an Actionable Therapeutic Target Across Human Malignancies.

Carly D Miller, John R Lozada, Nicholas A Zorko

|Jun 21, 2023
NK Cells from Human Cytomegalovirus-Seropositive Individuals Have a Distinct Metabolic Profile That Correlates with Elevated mTOR Signaling.

John R Lozada, Bin Zhang, Jeffrey S Miller

|May 01, 2023
Metastatic Prostate Cancers with BRCA2 versus ATM Mutations Exhibit Divergent Molecular Features and Clinical Outcomes.

Justin Hwang, Xiaolei Shi, Andrew Elliott

Pageof 2

Frequent Collaborators

5 joint publications

Justin Hwang

4 joint publications

Andrew Elliott

4 joint publications

Frank Cichocki

4 joint publications

Emmanuel S Antonarakis